CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹169 Cr | ₹184 Cr | ₹142 Cr | ₹192 Cr | ₹344 Cr |
What is the latest Total Current Liabilities ratio of CONCORD BIOTECH ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹169 Cr |
| Mar2025 | ₹184 Cr |
| Mar2024 | ₹142 Cr |
| Mar2023 | ₹192 Cr |
| Mar2022 | ₹344 Cr |
How is Total Current Liabilities of CONCORD BIOTECH Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹169 Cr | -8.14 | |
| Mar2025 | ₹184 Cr | 29.48 | |
| Mar2024 | ₹142 Cr | -25.90 | |
| Mar2023 | ₹192 Cr | -44.27 | |
| Mar2022 | ₹344 Cr | - | |
Compare Total Current Liabilities of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹13,274.3 Cr | 8.7% | -6.7% | -12.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,803.0 Cr | 0.9% | -5% | 3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,833.0 Cr | 3.6% | -1.4% | 37.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,461.0 Cr | 1.7% | -6.7% | 28% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,463.0 Cr | 5.4% | 8.7% | 1.6% | Stock Analytics | |
| CIPLA | ₹109,870.0 Cr | 2.8% | -3.9% | -17.5% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | 8.7% |
-6.7% |
-12.8% |
| SENSEX | -0.6% |
-0.5% |
-13.2% |
You may also like the below Video Courses